Cubicin
These highlights do not include all the information needed to use CUBICIN safely and effectively. See full prescribing information for CUBICIN. CUBICIN (daptomycin for injection), for Intravenous UseInitial U.S. Approval: 2003
Approved
Approval ID
a7975871-46a6-4e9b-a8b5-38bfcb465f0e
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Aug 24, 2023
Manufacturers
FDA
Merck Sharp & Dohme LLC
DUNS: 118446553
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Daptomycin
PRODUCT DETAILS
NDC Product Code67919-011
Application NumberNDA021572
Marketing CategoryC73594
Route of AdministrationINTRAVENOUS
Effective DateNovember 22, 2022
Generic NameDaptomycin
INGREDIENTS (2)
DaptomycinActive
Quantity: 500 mg in 10 mL
Code: NWQ5N31VKK
Classification: ACTIB
Sodium HydroxideInactive
Code: 55X04QC32I
Classification: IACT